Form 4 Filing for Beam Therapeutics Inc. - Shaw Christi

This filing details a Form 4 filed by Shaw Christi, a director at Beam Therapeutics Inc. On June 3, 2026, Shaw Christi was granted 19,676 stock options with a purchase price of $0.00 per share, exercisable under specific conditions. The options are for the company's Common Stock and will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the next annual meeting, contingent upon continued service. The options have an expiration date of June 3, 2036. The filing also indicates a conversion or exercise price of $29.55, and post-transaction shares owned are 19,676. The transaction code is "A" for acquisition.